Cargando…
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
Over the past decade, the tumor microenvironment (TME) has become a new paradigm of cancer diagnosis and therapy due to its unique biological features, mainly the interconnection between cancer and stromal cells. Within the TME, cancer-associated fibroblasts (CAFs) demonstrate as one of the most cri...
Autores principales: | Imlimthan, Surachet, Moon, Euy Sung, Rathke, Hendrik, Afshar-Oromieh, Ali, Rösch, Frank, Rominger, Axel, Gourni, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540221/ https://www.ncbi.nlm.nih.gov/pubmed/34681246 http://dx.doi.org/10.3390/ph14101023 |
Ejemplares similares
-
Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature
por: Escudero-Castellanos, Alondra, et al.
Publicado: (2023) -
Effect of the versatile bifunctional chelator AAZTA(5) on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist
por: Hofstetter, Michael, et al.
Publicado: (2020) -
Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021) -
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer
por: Birindelli, Gabriele, et al.
Publicado: (2021) -
Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
por: Lumen, Dave, et al.
Publicado: (2019)